Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States after an investigation found the devices operate as intended. J&J resumes ...

Change your smartphone wallpaper, and suddenly, you’ll feel like you’re holding a whole new device. Changing the wallpaper on your Android is also a straightforward task. What’s hard is find ...

If you’re looking to dramatically change a room but don’t want to spend a lot of money, time, or even be especially committed to the results, consider removable wallpaper — specifically the ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: scielo@scielo.org ...

Police should record more non-crime hate incidents, a leaked Home Office report has recommended, despite a row sparked by Telegraph journalist Allison Pearson. The counter-extremism review ...

As per ET, the health ministry had sought the legal affairs department's view on its final draft notification on allowing small pharmaceutical companies more time for upgrading their facilities to ...

The change has effectively pushed out many foreign pharmaceutical companies that do not want to compete against Chinese companies willing to sell their drugs at rock-bottom prices. Now ...

That secret British dossier that was “buried” by the late Queen. There could not be a more combustible or powerful moment for it to be unsealed than now. To understand how we got here ...

We would like to share some important news with you. After years of bringing you the latest insights, analysis and innovation news from the pharma industries, we have made the difficult decision to ...

Deerfield Management and J&J’s venture arm are among the investors backing Perceive Pharma, which on Tuesday raised $15 million for a preclinical glaucoma program.

Credit: Andrey Zhuravlev via Getty Images. China-based biotech Ascentage Pharma has raised $126m in a US initial public offering (IPO), marking the first biotech IPO of 2025. The company sold ...